XML 227 R82.htm IDEA: XBRL DOCUMENT
v3.25.2

Additional Information to the Items of Profit or Loss - Schedule of Additional Information to the Items of Profit or Loss (Details) - USD ($) $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022
a. Research and development expenses: |  |  |  |  |
Research and development expenses | $ 1,707 | $ 1,641 |  | $ 2,803 |
b. Sales and marketing expenses: |  |  |  |  |
Sales and marketing expenses | 1,515 | 2,484 | [1] | 1,082 | [1]
c. General and administrative expenses: |  |  |  |  |
General and administrative expenses | 4,526 | 3,844 | [1],[2] | 5,427 | [1]
d. Other expenses (income): |  |  |  |  |
Other expenses (income) | (1,270) |  |  |  |
e. Finance income: |  |  |  |  |
Finance income | (612) | (2,219) |  | (7,832) |
f. Finance expenses: |  |  |  |  |
Finance expenses | 353 | 1,055 |  | 2,014 |
Wages and related expenses [Member] |  |  |  |  |
a. Research and development expenses: |  |  |  |  |
Research and development expenses | 390 | 392 |  | 436 |
c. General and administrative expenses: |  |  |  |  |
General and administrative expenses | 507 | 415 |  | 437 |
Share-based payment [Member] |  |  |  |  |
a. Research and development expenses: |  |  |  |  |
Research and development expenses | 45 | 34 |  | 264 |
c. General and administrative expenses: |  |  |  |  |
General and administrative expenses | 419 | 68 |  | 633 |
Regulatory, professional and other expenses [Member] |  |  |  |  |
a. Research and development expenses: |  |  |  |  |
Research and development expenses | 681 | 719 |  | 750 |
Research and preclinical studies [Member] |  |  |  |  |
a. Research and development expenses: |  |  |  |  |
Research and development expenses | 211 | 101 |  | 703 |
Clinical studies [Member] |  |  |  |  |
a. Research and development expenses: |  |  |  |  |
Research and development expenses | 276 | 254 |  | 369 |
Chemistry and formulations [Member] |  |  |  |  |
a. Research and development expenses: |  |  |  |  |
Research and development expenses | 104 | 141 |  | 281 |
Advertising [Member] |  |  |  |  |
b. Sales and marketing expenses: |  |  |  |  |
Sales and marketing expenses | 367 | 576 |  | 363 |
Amazon fees [Member] |  |  |  |  |
b. Sales and marketing expenses: |  |  |  |  |
Sales and marketing expenses | 495 | 1,042 | [2] | 454 | [2]
Depreciation [Member] |  |  |  |  |
b. Sales and marketing expenses: |  |  |  |  |
Sales and marketing expenses | 366 | 486 |  | 144 |
Storage and shipping [Member] |  |  |  |  |
b. Sales and marketing expenses: |  |  |  |  |
Sales and marketing expenses | 167 | 145 | [2] | 91 | [2]
Management fees [Member] |  |  |  |  |
b. Sales and marketing expenses: |  |  |  |  |
Sales and marketing expenses | 120 | 235 |  | 30 |
Professional and directors’ fees [Member] |  |  |  |  |
c. General and administrative expenses: |  |  |  |  |
General and administrative expenses | 3,009 | 2,594 |  | 2,468 |
Business development expenses [Member] |  |  |  |  |
c. General and administrative expenses: |  |  |  |  |
General and administrative expenses | 108 | 86 |  | 161 |
Regulatory expenses [Member] |  |  |  |  |
c. General and administrative expenses: |  |  |  |  |
General and administrative expenses | 158 | 202 |  | 162 |
Office maintenance, rent and other expenses [Member] |  |  |  |  |
c. General and administrative expenses: |  |  |  |  |
General and administrative expenses | 128 | 110 |  | 80 |
Investor relations and business expenses [Member] |  |  |  |  |
c. General and administrative expenses: |  |  |  |  |
General and administrative expenses | 197 | 369 |  | 1,486 |
Loss from sale of property and equipment [Member] |  |  |  |  |
d. Other expenses (income): |  |  |  |  |
Other expenses (income) | 17 |  |  |  |
Gain on sale of patent license, net (net of Polyrizon Ltd. holdings sold) [Member] |  |  |  |  |
d. Other expenses (income): |  |  |  |  |
Other expenses (income) | (1,287) |  |  |  |
Net change in fair value of financial liabilities designated at fair value through profit or loss [Member] |  |  |  |  |
e. Finance income: |  |  |  |  |
Finance income | (191) | (2,205) |  | (7,832) |
Interest from loans to related parties and deposits [Member] |  |  |  |  |
e. Finance income: |  |  |  |  |
Finance income | (421) |  |  |  |
Exchange rate differences, net [Member] |  |  |  |  |
e. Finance income: |  |  |  |  |
Finance income |  | (14) |  |  |
f. Finance expenses: |  |  |  |  |
Finance expenses | 18 |  |  | 4 |
Issuance expenses related to warrants [Member] |  |  |  |  |
f. Finance expenses: |  |  |  |  |
Finance expenses |  |  |  | 1,204 |
Losses from remeasurement of investment in financial assets [Member] |  |  |  |  |
f. Finance expenses: |  |  |  |  |
Finance expenses | 305 | 1,046 |  | 770 |
Finance expense in respect of leases [Member] |  |  |  |  |
f. Finance expenses: |  |  |  |  |
Finance expenses | 8 | 9 |  | 15 |
Finance expenses from interest and commissions [Member] |  |  |  |  |
f. Finance expenses: |  |  |  |  |
Finance expenses | $ 22 |  |  | $ 21 |
[1] | Reclassified
[2] | Reclassified

X
- Definition The amount of costs associated with financing activities of the entity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 82 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_b&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_FinanceCosts
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of income associated with interest and other financing activities of the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 85 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_85&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_FinanceIncome
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of expense relating to general and administrative activities of the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 112 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_112_c&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_GeneralAndAdministrativeExpense
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of finance income or cost that the entity does not separately disclose in the same statement or note. [Refer: Finance income (cost)] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 85 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_85&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_OtherFinanceIncomeCost
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of expenditure directly attributable to research or development activities, recognised in profit or loss. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 38 -IssueDate 2024-01-01 -Paragraph 126 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_126&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ResearchAndDevelopmentExpense
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of expense relating to the marketing and selling of goods or services. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 85 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_85&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_SalesAndMarketingExpense
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_AResearchAndDevelopmentExpensesAbstract
Namespace Prefix: | sprcy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_BSalesAndMarketingExpensesAbstract
Namespace Prefix: | sprcy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_CGeneralAndAdministrativeExpensesAbstract
Namespace Prefix: | sprcy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_DOtherExpensesIncomeAbstract
Namespace Prefix: | sprcy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_EFinanceIncomeAbstract
Namespace Prefix: | sprcy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_FFinanceExpensesAbstract
Namespace Prefix: | sprcy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_WagesAndRelatedExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ShareBasedPaymentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_RegulatoryProfessionalAndOtherExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ResearchAndPreclinicalStudiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ClinicalStudiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ChemistryAndFormulationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_AdvertisementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_AmazonFeesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_DepreciationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_StorageAndShippingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ManagementFeesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ProfessionalAndDirectorsFeesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_BusinessDevelopmentExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_RegulatoryExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_OfficeMaintenanceRentAndOtherExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_InvestorRelationsAndBusinessExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_LossFromSaleOfPropertyAndEquipmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_GainOnSaleOfPatentLicenseNetnetOfPolyrizonLtdHoldingsSoldMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_NetChangeInFairValueOfFinancialLiabilitiesDesignatedAtFairValueThroughProfitOrLossMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_InterestFromLoansToRelatedPartiesAndDepositsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ExchangeRateDifferencesNetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_IssuanceExpensesRelatedToWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_LossesFromRemeasurementOfInvestmentInFinancialAssetsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_FinanceExpenseInRespectOfLeasesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_FinanceExpensesFromInterestAndCommissionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |